Riskpilot← Back to searchSign inGet full accessResMed Denmark A/S
A/SActiveCVR 30699246Kidnakken 11Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200722 employees
Revenue 2025
DKK 27,1M
+23% vs 2024
EBITDA margin
35.6%
+32% vs 2024
Equity ratio
71.0%
Financial strength
Net profit 2025
DKK 7,6M
+29% vs 2024
| Revenue | DKK 27,1M | +23% |
| EBITDA | DKK 9,6M | +32% |
| Net profit | DKK 7,6M | +29% |
| Total assets | DKK 59,2M | +6% |
| Equity | DKK 42M | +22% |
| Employees | 22 | — |
Legal name
ResMed Denmark A/S
CVR number
30699246
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27. juni 2007
Share capital
DKK 556.000
Employees
22 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af et bestyrelsesmedlem i forening med direktionen eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive handel og industri.
Address
Kidnakken 11
Phone
+4554757549
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -25.559 | — | — | 31.808 | 16.555 | 16.496 | 12.524 | 13.914 | 15.492 | 18.230 | 21.978 | 21.992 | 27.104 |
| Staff expenses | -8.802 | -0 | -0 | -20.395 | -11.151 | -11.059 | -10.835 | -10.454 | -11.011 | -13.231 | -14.576 | -14.694 | -17.455 |
| EBITDA | -16.440 | 0 | 0 | 11.413 | 5.404 | 5.438 | 1.690 | 3.460 | 4.481 | 4.999 | 7.402 | 7.298 | 9.648 |
| Depreciation & amort. | -159 | -0 | -0 | -208 | -276 | -264 | -206 | -63 | -40 | -22 | -9 | -18 | -65 |
| EBIT | -16.599 | 0 | 0 | 11.205 | 5.128 | 5.174 | 1.483 | 3.396 | 4.441 | 4.977 | 7.393 | 7.280 | 9.584 |
| Net financials | 11.148 | 0 | 0 | -7 | -22 | -51 | -40 | -38 | -68 | -84 | 68 | 316 | 215 |
| Profit before tax | -5.449 | 0 | 0 | 11.198 | 5.106 | 5.123 | 1.443 | 3.358 | 4.373 | 4.893 | 7.461 | 7.596 | 9.799 |
| Tax | -4.186 | -0 | -0 | 2.634 | 1.160 | 1.188 | 319 | 741 | 969 | 1.080 | 1.643 | 1.673 | 2.158 |
| Net profit | -1.263 | 0 | 0 | 8.564 | 3.946 | 3.936 | 1.124 | 2.617 | 3.404 | 3.813 | 5.818 | 5.923 | 7.641 |
| Item | 2012 | 2013 | 2014 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 23.677 | 0 | 0 | 21.361 | 20.969 | 19.791 | 23.396 | 24.548 | 36.085 | 41.018 | 45.276 | 55.826 | 59.249 |
| Equity | 15.334 | 0 | 0 | 13.321 | 12.767 | 11.703 | 12.827 | 15.444 | 18.849 | 22.661 | 28.479 | 34.402 | 42.043 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 853 | 1.044 | 0 | 1.700 | 1.218 | 1.873 |
| Short-term debt | -8.344 | 0 | 0 | 8.040 | 8.202 | 7.558 | 9.806 | 7.311 | 15.168 | 17.266 | 12.939 | 17.839 | 12.611 |
| Total debt | -8.344 | 0 | 0 | 8.040 | 8.202 | 7.558 | 9.806 | 8.164 | 16.212 | 17.266 | 14.639 | 19.056 | 14.483 |
EBITDA margin
35.6%
This company
15.8%
Market median
+125% vs market
20122025
Equity ratio
71.0%
This company
38.2%
Market median
+86% vs market
20122025
Return on equity
18.2%
This company
18.4%
Market median
+1% vs market
20122025
Net profit margin
28.2%
This company
8.1%
Market median
+248% vs market
20122025
Asset turnover
0.46×
This company
1.12×
Market median
-59% vs market
20122025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-01-01 – 2016-06-30
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EV Management | Management | 2007 | — | — |
MB Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
MT Management | Management | 2007 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AB | Chairman | 2008 | — | — |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2013 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2007 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2025 | |
LOHE HOLDING ApS | Company | 15.0% | 15.0% | 2014 |
Toxholm Holding ApS | Company | 25.0% | 25.0% | 2014 |
| Individual | 100.0% | 100.0% | 2025 | |
| Individual | 100.0% | 100.0% | 2025 | |
| Individual | 100.0% | 100.0% | 2025 | |
| Individual | 100.0% | 100.0% | 2025 | |
LEF HOLDING ApS | Company | 50.0% | 50.0% | 2014 |
| Individual | 100.0% | 100.0% | 2015 | |
| Individual | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ResMed Denmark A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ebbe Viggo Frahm-Rasmussen | Management | 0 companies |
| Malene Brun Petersen | Chief Executive Officer | 0 companies |
| Mette Toxværd Larsen | Management | 0 companies |
| Arne Bøe | Chairman | 0 companies |
| Julie Nana Waras Brogren | Board of Directors | 0 companies |
| Birgitte Grabow Westergaard | Board of Directors | 0 companies |
| Henrik Birger Rask | Chairman | 0 companies |
| Jacob Stenholm Jensen | Board of Directors | 0 companies |
| Lasse Sørensen | Board of Directors | 0 companies |
| Nigel Wayne Robinson | Board of Directors | 0 companies |
| Anne Claude Andrée Armelle Joliot ép. Reiser | Board of Directors | 0 companies |
| Jussi Antero Vuorela | Board of Directors | 0 companies |
| David Brian Pendarvis | Board of Directors | 0 companies |
| Jens Viggo Frahm-Rasmussen | Board of Directors | 0 companies |
| Jens Juul Davidsen | Board of Directors | 0 companies |
| Michael James Rider | Chairman | 0 companies |
| Eric Raymond Cazergue | Board of Directors | 0 companies |